- Home
- FGEN vs RMCO Comparison
FGEN vs RMCO Comparison
Compare FGEN & RMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- RMCO
- Stock Information
- Founded
- FGEN 1993
- RMCO 2021
- Country
- FGEN United States
- RMCO United States
- Employees
- FGEN N/A
- RMCO N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- RMCO Multi-Sector Companies
- Sector
- FGEN Health Care
- RMCO Miscellaneous
- Exchange
- FGEN Nasdaq
- RMCO Nasdaq
- Market Cap
- FGEN 45.1M
- RMCO 45.7M
- IPO Year
- FGEN 2014
- RMCO N/A
- Fundamental
- Price
- FGEN $8.66
- RMCO $2.92
- Analyst Decision
- FGEN Strong Buy
- RMCO Buy
- Analyst Count
- FGEN 2
- RMCO 1
- Target Price
- FGEN $146.50
- RMCO N/A
- AVG Volume (30 Days)
- FGEN 31.2K
- RMCO 70.5K
- Earning Date
- FGEN 11-10-2025
- RMCO 11-13-2025
- Dividend Yield
- FGEN N/A
- RMCO 0.34%
- EPS Growth
- FGEN N/A
- RMCO N/A
- EPS
- FGEN 53.38
- RMCO N/A
- Revenue
- FGEN $8,298,000.00
- RMCO $3,798,352.00
- Revenue This Year
- FGEN N/A
- RMCO $6,850.91
- Revenue Next Year
- FGEN N/A
- RMCO $20.00
- P/E Ratio
- FGEN $0.16
- RMCO N/A
- Revenue Growth
- FGEN N/A
- RMCO 445.90
- 52 Week Low
- FGEN $4.85
- RMCO $0.90
- 52 Week High
- FGEN $21.94
- RMCO $4.76
- Technical
- Relative Strength Index (RSI)
- FGEN 25.08
- RMCO 45.73
- Support Level
- FGEN $8.30
- RMCO $2.81
- Resistance Level
- FGEN $11.39
- RMCO $3.49
- Average True Range (ATR)
- FGEN 0.51
- RMCO 0.26
- MACD
- FGEN -0.26
- RMCO -0.08
- Stochastic Oscillator
- FGEN 12.95
- RMCO 4.79
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About RMCO Royalty Management Holding Corporation
Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.